Accelerate to discover

Back to filter

Related topics

IncuCyte white paper: live-cell analysis for Neuroscientists

Sartorius

Mar 20, 2019

Stem cell technologies using iPSCs allow researchers to create differentiated neurons and support cells to study human...

Cell plasticity associated to circulating tumor cells from prostate cancer patients

Fluxion Biosciences

Mar 13, 2019

Treatment resistance is associated with tumor cells molecular plasticity. In metastatic castration resistant prostate...

Izon qEV - The fastest & most effective Exosome isolation

IZON

Mar 6, 2019

Extracellular  vesicles  (EVs)  are  prevalent  in biological  fluids  and  are  of  great  interest  to researchers ...

Enhanced uptake of luminescent quantum dots by live cells

Etaluma

Mar 1, 2019

The steady progress made over the past threedecades in growing a variety of inorganic nanomaterials, with discreet...

Mar 21, 2019

Fat-water separation Imaging in Preclinical MRI

Bruker Biospin

Mar 1, 2019

Non-invasive in vivo phenotyping of adipose tissue deposits in small animal models is of great importance in...

New technique for dynamic monitoring of liquid tumor Cytotoxicity

Acea Biosciences

Feb 12, 2019

To develop and validate immuno-oncology therapies, scientists must understand the full dynamics of cytotoxic effectors...

Small animal 13C-hyperpolarized MRI

Bruker Biospin

Feb 8, 2019

13C-Hyperpolarized molecules provide a unique signature for molecular processes relevant to a range of disease...

Mar 21, 2019

Oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts

Spectral Instruments Imaging

Jan 30, 2019

Pancreatic ductal adenocarcinoma has been increasing by 0.5% per year in the United States. This study describes the...

Show all topics (10)

Preclinical imaging for drug discovery and development

Dec 12, 2016

Advances in multimodal preclinical imaging enable tracking of physiologic and structural changes together in vivo, for highly efficient longitudinal studies of disease progress and drug distribution, delivery and therapeutic response. Same-session X-ray, PET, SPECT, and/or optical views - automatically co-registered - provide detailed anatomic context for physiological metrics such as candidate biomarkers. Advanced software and techniques like spectral unmixing enable tracking of multiple measures together - for example, quantifying critical gene and protein expression, or co-locating a drug compound and its target.

Bruker's modular multimodal imaging systems let you choose which modalities to use with the option to add modalities as needed later, all within the same, small footprint. For highly detailed anatomic and functional studies, Bruker MRI and magnetic particle imaging systems provide outstanding spatial and time resolution, and complement clinical imaging methods for rapid translation of study results between animals and patients.

Learn more about preclinical imaging methods for drug discovery and development.

Read more

 

Scientific paper
Application

Related technologies: PET, SPECT, CT | Magnetic resonance imaging

Get more info

Miroslav Vecheta

Support specialist

Miroslav

Vecheta

+420 255 700 886

Send Message

Brand profile

Bruker Biospin

Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.

Related products

Albira combines PET, SPECT and CT imaging in a unique and extremely powerful way

show detail

MRI and PET imaging combined for the best of both worlds

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey